Abstract
Background
To describe long-term survival and cardiovascular events in adult patients with single
ventricle physiology (SVP) without Fontan palliation, focusing on predictors of mortality
and comparing groups according to their cardiovascular physiology.
Methods
Multicentre observational and retrospective study including adult patients with SVP
without Fontan palliation since their first adult clinic visit. The cohort was subdivided
into 3 groups: Eisenmenger, restricted pulmonary flow, and aortopulmonary shunt. Death
was considered as the main end point. Other clinical outcomes occurring during follow-up
were considered as secondary end points.
Results
A total of 146 patients, mean age 32.5 ± 11.1 years, were analysed. Over a mean follow-up
of 7.3 ± 4.1 years, 33 patients (22.6%) died. Survival was 86% and 74% at 5 and 10
years, respectively. Right ventricular morphology was not associated with higher mortality.
Four variables at baseline were related to a higher mortality: at least moderate atrioventricular
valve regurgitation, platelet count < 150 × 103/mm3, GFR < 60 mL/min/1.73 m2, and QRS > 120 ms). A total of 34.2% of patients were admitted to the hospital due
to heart failure, and 7.5% received a heart transplant. Other cardiovascular outcomes
were also frequent: atrial arrhythmias in 19.2%, stroke in 15.1%, and pacemaker/implantable
cardioverter-defibrillator in 6.2%/2.7%.
Conclusions
Adult patients with SVP who had not undergone Fontan exhibit a high mortality rate
and frequent major cardiovascular events. At least moderate atrioventricular valve
regurgitation, thrombocytopenia, renal dysfunction, and QRS duration > 120 ms at baseline
visit allow identification of a cohort of patients at higher risk of mortality.
Résumé
Objectif
Décrire la survie à long terme et les événements cardiovasculaires chez les patients
adultes présentant une physiologie à ventricule unique (PVU) sans intervention de
Fontan, en se concentrant sur les prédicteurs de mortalité et en comparant les groupes
en fonction de leur physiologie cardiovasculaire.
Méthodes
Étude observationnelle et rétrospective, multicentrique, incluant des patients adultes
atteints de PVU sans intervention de Fontan depuis leur première visite en clinique
adulte. La cohorte a été subdivisée en trois groupes : syndrome d'Eisenmenger, flux
pulmonaire restreint ou fenêtre aorto-pulmonaire. Le décès a été considéré comme le
critère principal d'évaluation. Les autres observations cliniques survenues au cours
du suivi ont été considérées comme des critères secondaires.
Résultats
Un total de 146 patients, d'un âge moyen de 32,5 ± 11,1 ans, a été considéré pour
l’analyse. Sur un suivi moyen de 7,3 ± 4,1 ans, 33 patients (22,6 %) sont décédés.
La survie était de 86 % et 74 % à 5 et 10 ans, respectivement. La morphologie du ventricule
droit n'était pas associée à une mortalité plus élevée. Quatre variables initiales
étaient liées à une mortalité plus élevée : régurgitation au moins modérée de la valve
auriculo-ventriculaire, numération plaquettaire < 150 × 103/mm3, DFG < 60 ml/min/1,73 m2 et QRS > 120 ms). Au total, 34,2 % des patients ont été admis à l'hôpital en raison
d'une insuffisance cardiaque, et 7,5 % ont reçu une transplantation cardiaque. D'autres
conséquences cardiovasculaires étaient également fréquentes : arythmies auriculaires
dans 19,2 % des cas, accident vasculaire cérébral dans 15,1 % des cas et stimulateur
cardiaque/ défibrillateur cardioverteur implantable dans 6,2 % / 2,7 % des cas.
Conclusions
Les patients adultes atteints de PVU qui n'ont pas subi d'intervention de Fontan présentent
un taux de mortalité élevé et des événements cardiovasculaires majeurs fréquents.
Une régurgitation au moins modérée de la valve auriculo-ventriculaire, une thrombocytopénie,
une dysfonction rénale et une durée du QRS > 120 ms lors de la visite initiale permettent
de distinguer une cohorte de patients présentant un risque de mortalité plus élevé.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The new concept of univentricular heart.Front Pediatr. 2014; 2: 62
- Anatomic types of single or common ventricle in man.Am J Cardiol. 1964; 13: 367-386
- Surgical repair of tricuspid atresia.Thorax. 1971; 26: 240-248
- Univentricular hearts in Denmark 1977 to 2009: incidence and survival.Int J Cardiol. 2013; 167: 1311-1316
- Definitive palliation with cavopulmonary or aortopulmonary shunts for adults with single ventricle physiology.Heart. 2000; 83: 51-57
- Survival and outcomes of patients with unoperated single ventricle.Heart. 2016; 102: 216-222
- Outcome of the Glenn procedure as definitive palliation in single ventricle patients.Int J Cardiol. 2020; 303: 30-35
- Long-term survival of patients with univentricular heart not treated surgically.J Thorac Cardiovasc Surg. 2002; 123: 1214-1217
- Predictors of death in contemporary adult patients with Eisenmenger syndrome: a multicenter study.Circulation. 2017; 135: 1432-1440
- Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease.J Am Coll Cardiol. 2006; 48: 356-365
- Circulatory bypass of the right side of the heart.N Engl J Med. 1958; 259: 117-120
- Long-term follow-up in the unoperated univentricular heart.Am J Cardiol. 1984; 53: 1124-1128
- Survival into adulthood of patients with unoperated single ventricle.Am J Cardiol. 1996; 77: 542-544
- Poor prognosis and related factors in adults with Eisenmenger syndrome.Am Heart J. 2002; 143: 739-744
- Risk factors for excess mortality in adults with congenital heart diseases.Eur Heart J. 2017; 38: 1233-1241
- Children and adults with congenital heart disease lost to follow-up: who and when?.Circulation. 2009; 120: 302-309
- Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease.Int J Cardiol. 2018; 254: 101-106
- Atrioventricular valve failure in fontan palliation.J Am Coll Cardiol. 2019; 73: 810-822
- The progress and significance of QRS duration by electrocardiography in hypoplastic left heart syndrome.Pediatr Cardiol. 2020; 41: 141-148
- Thrombocytopenia in congenital heart disease patients.Platelets. 2015; 26: 432-436
- Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease—Japanese multi-center study.Int J Cardiol. 2007; 120: 72-78
- Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome.Heart. 2018; 104: 45-50
- Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.Circulation. 2008; 117: 2320-2328
- QRS duration changes in patients with single ventricle physiology: birth to 10 years.Pacing Clin Electrophysiol. 2015; 38: 1159-1165
- Adults with congenital heart disease and heart transplantation: optimizing outcomes.J Heart Lung Transplant. 2014; 33: 873-877
- Bidirectional cavopulmonary shunt with additional pulmonary blood flow: a failed or successful strategy?.Eur J Cardiothorac Surg. 2012; 42: 513-519
- Pulsatile Glenn as long-term palliation for single ventricle physiology patients.Congenit Heart Dis. 2018; 13: 927-934
Article Info
Publication History
Published online: June 08, 2021
Accepted:
June 2,
2021
Received:
December 9,
2020
Footnotes
See editorial by Massarella and Oechslin, pages 858–861 of this issue.
See page 1119 for disclosure information.
Identification
Copyright
© 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
